DOH: Duque will be vaccinated when 'appropriate' Covid-19 jab 'becomes available' | Inquirer News

DOH: Duque will be vaccinated when ‘appropriate’ Covid-19 jab ‘becomes available’

HEALTH CHIEF WAS NOT AND WILL NOT BE VACCINATED WITH CORONAVAC
/ 03:19 PM March 01, 2021

DOH: Duque will be vaccinated when 'appropriate' Covid-19 jab 'becomes available'

Health Secretary Francisco Duque III. INQUIRER FILE PHOTO / EDWIN BACASMAS

MANILA, Philippines — Health Secretary Francisco Duque III will be inoculated when the “appropriate” Covid-19 vaccine “becomes available,” according to the Department of Health (DOH), clarifying what presidential spokesperson Harry Roque has said that the health chief is also expected to get Sinovac.

“To clarify, he will be vaccinated when the appropriate vaccine becomes available, following of course the prioritization framework,” DOH said in a Viber message to reporters on Monday.

Article continues after this advertisement

The DOH Communications Management Unit also stressed that Duque was not and will not be vaccinated with CoronaVac, the Covid-19 vaccine developed by Sinovac of China.

FEATURED STORIES

“No, SOH (Secretary of Health) was not and will not be vaccinated,” a staff at the DOH Communications Management Unit told reporters in a separate message when asked if Duque was vaccinated against Covid-19 on the first day of the inoculation day.

Duque was among guests on the first day of vaccination at the Lung Center of the Philippines in Quezon City.

Article continues after this advertisement

During the press briefing at the Philippine General Hospital (PGH), Roque said Duque was expected to get CoronaVac. PGH was among the first hospitals that received a portion of the 600,000 doses of the Sinovac vaccine that was donated by China.

Article continues after this advertisement

“Ang alam ko po si Secretary Duque. Si Secretary Galvez, although as I said, he opted na mauna na muna ‘yung mga frontliners,” Roque said when asked who among the Duterte Cabinet members will be included as beneficiaries of the China-donated Covid-19 jab.

Article continues after this advertisement

(I know Secretary Duque will get the vaccine. Secretary Galvez will also get vaccinated but he opted that the front liners get inoculated first.)

“Si Secretary Duque po nasa Lung Center, inaasahan rin nating magpapabakuna (Secretary Duque is at the Lung Center. We expect that he will also be vaccinated),” he also said later during the briefing.

Article continues after this advertisement

On Sunday night, DOH said 64-year-old Duque will not get Sinovac’s CoronaVac because of the age restriction recommended by the Food and Drug Administration (FDA) for the vaccine made in China.

FDA Director-General Eric Domingo earlier said CoronaVac should only be administered to clinically healthy individuals aged 18 to 59, as the vaccine showed higher efficacy rates in this age group based on clinical trials in Indonesia and Turkey.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Coronavac, Coronavirus, coronavirus Philippines, COVID-19, Harry Roque, Health, pandemic, SARS-CoV-2, vaccine, Virus

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.